USD10
FOLD Shares
About Amicus TherapeuticsAmicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
USD10
FOLD Shares
About Amicus TherapeuticsAmicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Stats
TRADING WINDOW
Closed
OPENS AT
Apr 10 at 1:30 PM GMT+0
MARKET CAP
$4.54B
OPEN PRICE
Not enough data
LOW (1Y)
$5.51
HIGH (1Y)
$14.48
LOW (24H)
$14.46
HIGH (24H)
$14.47
VOLUME (24H)
$1.27M
29.55%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $14.46 | |
1 Week | $16.00 | |
1 Month | $14.35 | |
1 Year | $6.48 |
Past performance is not a reliable indicator of future results.
Discover more
Popular stocks
Explore other stocks
Popular cryptocurrencies
Most popular conversions
Popular derivatives
Learn how to buy popular cryptocurrencies
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
